BrightSpring Health Services, Inc. Financing Receivable, Credit Loss, Expense (Reversal)
BrightSpring Health Services, Inc. (BTSG) reported Financing Receivable, Credit Loss, Expense (Reversal) of $22.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLossesExpensed · last filed 2026-07-31
- BrightSpring Health Services, Inc. financing receivable, credit loss, expense (reversal) for the quarter ending 2026-06-30 was $12.31M, a 62.20% decline year-over-year.
- BrightSpring Health Services, Inc. financing receivable, credit loss, expense (reversal) for the quarter ending 2026-03-31 was $10.56M, a 30.34% increase year-over-year.
- BrightSpring Health Services, Inc. financing receivable, credit loss, expense (reversal) for the quarter ending 2025-12-31 was $7.50M, a 37.99% decline year-over-year.
- BrightSpring Health Services, Inc. financing receivable, credit loss, expense (reversal) for the quarter ending 2025-09-30 was $8.06M, a 8.12% decline year-over-year.
- BrightSpring Health Services, Inc. financing receivable, credit loss, expense (reversal) for fiscal 2025 was $56.23M, a 65.38% increase from fiscal 2024.
- BrightSpring Health Services, Inc. financing receivable, credit loss, expense (reversal) for fiscal 2024 was $34.00M, a 46.31% increase from fiscal 2023.
- BrightSpring Health Services, Inc. financing receivable, credit loss, expense (reversal) for fiscal 2023 was $23.24M.
| Period end | Financing Receivable, Credit Loss, Expense (Reversal) 3 month | Financing Receivable, Credit Loss, Expense (Reversal) 6 month | Financing Receivable, Credit Loss, Expense (Reversal) 9 month | Financing Receivable, Credit Loss, Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $22.86M 10-Q · filed 2026-07-31 | $30.37M derived: sum of 3 quarters · filed 2026-07-31 | $38.43M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $10.56M 10-Q · filed 2026-05-01 | $18.06M derived: sum of 2 quarters · filed 2026-05-01 | $26.13M derived: sum of 3 quarters · filed 2026-05-01 | $58.69M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $15.57M derived: sum of 2 quarters · filed 2026-02-27 | $48.13M derived: sum of 3 quarters · filed 2026-07-31 | $56.23M 10-K · filed 2026-02-27 |
| 2025-09-30 | $8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $40.62M derived: sum of 2 quarters · filed 2026-07-31 | $48.72M 10-Q · filed 2025-10-28 | $60.83M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $32.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $40.66M 10-Q · filed 2026-07-31 | $52.76M derived: sum of 3 quarters · filed 2026-07-31 | $61.54M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $8.10M 10-Q · filed 2026-05-01 | $20.20M derived: sum of 2 quarters · filed 2026-05-01 | $28.98M derived: sum of 3 quarters · filed 2026-05-01 | $35.48M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $20.88M derived: sum of 2 quarters · filed 2026-02-27 | $27.38M derived: sum of 3 quarters · filed 2026-02-27 | $34.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $15.27M derived: sum of 2 quarters · filed 2025-10-28 | $21.90M 10-Q · filed 2025-10-28 | $26.21M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $13.12M 10-Q · filed 2025-08-01 | $17.43M derived: sum of 3 quarters · filed 2026-02-27 | $24.18M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $6.62M 10-Q · filed 2025-05-02 | $10.93M derived: sum of 2 quarters · filed 2026-02-27 | $17.68M derived: sum of 3 quarters · filed 2026-02-27 | $23.64M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $11.06M derived: sum of 2 quarters · filed 2026-02-27 | $17.02M derived: sum of 3 quarters · filed 2026-02-27 | $23.24M 10-K · filed 2026-02-27 |
| 2023-09-30 | $6.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $12.71M derived: sum of 2 quarters · filed 2024-11-01 | $18.93M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $5.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $12.17M 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | $6.22M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $15.06M 8-K · filed 2025-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHEMED CORP (CHE) | United States | $6.474B | 22.14 |
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |